The favorable anti-leukemic effect of the inhibitor on the most sensitive cell line was substantiated by apoptosis analysis, where we found that the lower concentrations of 10058-F4 induced a caspase-3-dependent apoptosis in APL-derived NB4 cells. This evidence concerns the gene CASP3 and acute promyelocytic leukemia.